Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease
We describe here a patient with mixed connective tissue disease (MCTD) who developed severe rhabdomyolysis during treatment with pravastatin sodium, another HMG-CoA reductase inhibitor which has been reported to induce myopathy (6,7). This patient had normal renal function and had not taken any of t...
Gespeichert in:
| Veröffentlicht in: | Arthritis and rheumatism 1996-07, Vol.39 (7), p.1259-1260 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1260 |
|---|---|
| container_issue | 7 |
| container_start_page | 1259 |
| container_title | Arthritis and rheumatism |
| container_volume | 39 |
| creator | Hino, Ikuko Akama, Hideto Furuya, Takefumi Ueda, Hiroyuki Taniguchi, Atsuo Hara, Masako Kashiwazaki, Sadao |
| description | We describe here a patient with mixed connective tissue disease (MCTD) who developed severe rhabdomyolysis during treatment with pravastatin sodium, another HMG-CoA reductase inhibitor which has been reported to induce myopathy (6,7). This patient had normal renal function and had not taken any of the above-mentioned medications previously known to possibly potentiate this adverse effect. |
| doi_str_mv | 10.1002/art.1780390730 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16034208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16034208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4000-618da7076a99393a30e3fccd0cf74e040879cf7d09f8eee27bf428dc6f2937693</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhiMEgjG4ckPqAXHrcJquaY5o4ktCAiHgWmWJK4L6MeJ2Yzd-Ar-RX0KmTcCNk2358Wv7ZeyIw4gDJGfadyMucxAKpIAtNuDjRMXABd9mAwBIYzFWfI_tE72GMhFjsct280yCSPmAPd97PdfU6c41Xx-frrG9QRv5Fz21bb1sqyU5ilwT6WgWGGy6aOG6l6h27wEzbdOg6dwco84R9RhZR6gJD9hOqSvCw00csqfLi8fJdXx7d3UzOb-NTRqOiTOeWy1BZlopoYQWgKI0xoIpZYqQQi5VSC2oMkfERE7LNMmtycpECZkpMWSna92Zb996pK6oHRmsKt1g21PBs_BmAnkAR2vQ-JbIY1nMvKu1XxYcipWRRTCy-DUyDBxvlPtpjfYH3zgX-iebviajq9Lrxjj6wQRPRcZXMmqNLVyFy3-WFucPj39O-Aarz43c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16034208</pqid></control><display><type>article</type><title>Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease</title><source>MEDLINE</source><source>Wiley Online Library</source><source>Alma/SFX Local Collection</source><creator>Hino, Ikuko ; Akama, Hideto ; Furuya, Takefumi ; Ueda, Hiroyuki ; Taniguchi, Atsuo ; Hara, Masako ; Kashiwazaki, Sadao</creator><creatorcontrib>Hino, Ikuko ; Akama, Hideto ; Furuya, Takefumi ; Ueda, Hiroyuki ; Taniguchi, Atsuo ; Hara, Masako ; Kashiwazaki, Sadao</creatorcontrib><description>We describe here a patient with mixed connective tissue disease (MCTD) who developed severe rhabdomyolysis during treatment with pravastatin sodium, another HMG-CoA reductase inhibitor which has been reported to induce myopathy (6,7). This patient had normal renal function and had not taken any of the above-mentioned medications previously known to possibly potentiate this adverse effect.</description><identifier>ISSN: 0004-3591</identifier><identifier>EISSN: 1529-0131</identifier><identifier>DOI: 10.1002/art.1780390730</identifier><identifier>PMID: 8670341</identifier><identifier>CODEN: ARHEAW</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; Enzyme Inhibitors - administration & dosage ; Enzyme Inhibitors - adverse effects ; Female ; Humans ; Medical sciences ; Middle Aged ; Mixed Connective Tissue Disease - drug therapy ; Pharmacology. Drug treatments ; Pravastatin - administration & dosage ; Pravastatin - adverse effects ; Rhabdomyolysis - chemically induced ; Rhabdomyolysis - complications ; Toxicity: skin, dermoskeleton</subject><ispartof>Arthritis and rheumatism, 1996-07, Vol.39 (7), p.1259-1260</ispartof><rights>Copyright © 1996 American College of Rheumatology</rights><rights>1996 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4000-618da7076a99393a30e3fccd0cf74e040879cf7d09f8eee27bf428dc6f2937693</citedby><cites>FETCH-LOGICAL-c4000-618da7076a99393a30e3fccd0cf74e040879cf7d09f8eee27bf428dc6f2937693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fart.1780390730$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fart.1780390730$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3143610$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8670341$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hino, Ikuko</creatorcontrib><creatorcontrib>Akama, Hideto</creatorcontrib><creatorcontrib>Furuya, Takefumi</creatorcontrib><creatorcontrib>Ueda, Hiroyuki</creatorcontrib><creatorcontrib>Taniguchi, Atsuo</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kashiwazaki, Sadao</creatorcontrib><title>Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease</title><title>Arthritis and rheumatism</title><addtitle>Arthritis Rheum</addtitle><description>We describe here a patient with mixed connective tissue disease (MCTD) who developed severe rhabdomyolysis during treatment with pravastatin sodium, another HMG-CoA reductase inhibitor which has been reported to induce myopathy (6,7). This patient had normal renal function and had not taken any of the above-mentioned medications previously known to possibly potentiate this adverse effect.</description><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Enzyme Inhibitors - administration & dosage</subject><subject>Enzyme Inhibitors - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mixed Connective Tissue Disease - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Pravastatin - administration & dosage</subject><subject>Pravastatin - adverse effects</subject><subject>Rhabdomyolysis - chemically induced</subject><subject>Rhabdomyolysis - complications</subject><subject>Toxicity: skin, dermoskeleton</subject><issn>0004-3591</issn><issn>1529-0131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PwzAMhiMEgjG4ckPqAXHrcJquaY5o4ktCAiHgWmWJK4L6MeJ2Yzd-Ar-RX0KmTcCNk2358Wv7ZeyIw4gDJGfadyMucxAKpIAtNuDjRMXABd9mAwBIYzFWfI_tE72GMhFjsct280yCSPmAPd97PdfU6c41Xx-frrG9QRv5Fz21bb1sqyU5ilwT6WgWGGy6aOG6l6h27wEzbdOg6dwco84R9RhZR6gJD9hOqSvCw00csqfLi8fJdXx7d3UzOb-NTRqOiTOeWy1BZlopoYQWgKI0xoIpZYqQQi5VSC2oMkfERE7LNMmtycpECZkpMWSna92Zb996pK6oHRmsKt1g21PBs_BmAnkAR2vQ-JbIY1nMvKu1XxYcipWRRTCy-DUyDBxvlPtpjfYH3zgX-iebviajq9Lrxjj6wQRPRcZXMmqNLVyFy3-WFucPj39O-Aarz43c</recordid><startdate>199607</startdate><enddate>199607</enddate><creator>Hino, Ikuko</creator><creator>Akama, Hideto</creator><creator>Furuya, Takefumi</creator><creator>Ueda, Hiroyuki</creator><creator>Taniguchi, Atsuo</creator><creator>Hara, Masako</creator><creator>Kashiwazaki, Sadao</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>199607</creationdate><title>Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease</title><author>Hino, Ikuko ; Akama, Hideto ; Furuya, Takefumi ; Ueda, Hiroyuki ; Taniguchi, Atsuo ; Hara, Masako ; Kashiwazaki, Sadao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4000-618da7076a99393a30e3fccd0cf74e040879cf7d09f8eee27bf428dc6f2937693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Enzyme Inhibitors - administration & dosage</topic><topic>Enzyme Inhibitors - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mixed Connective Tissue Disease - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Pravastatin - administration & dosage</topic><topic>Pravastatin - adverse effects</topic><topic>Rhabdomyolysis - chemically induced</topic><topic>Rhabdomyolysis - complications</topic><topic>Toxicity: skin, dermoskeleton</topic><toplevel>online_resources</toplevel><creatorcontrib>Hino, Ikuko</creatorcontrib><creatorcontrib>Akama, Hideto</creatorcontrib><creatorcontrib>Furuya, Takefumi</creatorcontrib><creatorcontrib>Ueda, Hiroyuki</creatorcontrib><creatorcontrib>Taniguchi, Atsuo</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kashiwazaki, Sadao</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Arthritis and rheumatism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hino, Ikuko</au><au>Akama, Hideto</au><au>Furuya, Takefumi</au><au>Ueda, Hiroyuki</au><au>Taniguchi, Atsuo</au><au>Hara, Masako</au><au>Kashiwazaki, Sadao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease</atitle><jtitle>Arthritis and rheumatism</jtitle><addtitle>Arthritis Rheum</addtitle><date>1996-07</date><risdate>1996</risdate><volume>39</volume><issue>7</issue><spage>1259</spage><epage>1260</epage><pages>1259-1260</pages><issn>0004-3591</issn><eissn>1529-0131</eissn><coden>ARHEAW</coden><abstract>We describe here a patient with mixed connective tissue disease (MCTD) who developed severe rhabdomyolysis during treatment with pravastatin sodium, another HMG-CoA reductase inhibitor which has been reported to induce myopathy (6,7). This patient had normal renal function and had not taken any of the above-mentioned medications previously known to possibly potentiate this adverse effect.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>8670341</pmid><doi>10.1002/art.1780390730</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0004-3591 |
| ispartof | Arthritis and rheumatism, 1996-07, Vol.39 (7), p.1259-1260 |
| issn | 0004-3591 1529-0131 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16034208 |
| source | MEDLINE; Wiley Online Library; Alma/SFX Local Collection |
| subjects | Biological and medical sciences Drug toxicity and drugs side effects treatment Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - adverse effects Female Humans Medical sciences Middle Aged Mixed Connective Tissue Disease - drug therapy Pharmacology. Drug treatments Pravastatin - administration & dosage Pravastatin - adverse effects Rhabdomyolysis - chemically induced Rhabdomyolysis - complications Toxicity: skin, dermoskeleton |
| title | Pravastatin‐induced rhabdomyolysis in a patient with mixed connective tissue disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T19%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pravastatin%E2%80%90induced%20rhabdomyolysis%20in%20a%20patient%20with%20mixed%20connective%20tissue%20disease&rft.jtitle=Arthritis%20and%20rheumatism&rft.au=Hino,%20Ikuko&rft.date=1996-07&rft.volume=39&rft.issue=7&rft.spage=1259&rft.epage=1260&rft.pages=1259-1260&rft.issn=0004-3591&rft.eissn=1529-0131&rft.coden=ARHEAW&rft_id=info:doi/10.1002/art.1780390730&rft_dat=%3Cproquest_cross%3E16034208%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16034208&rft_id=info:pmid/8670341&rfr_iscdi=true |